BioSig Technologies, Inc. announced its intention to offer shares of common stock through an underwritten public offering.
The company plans to use the net proceeds for purchasing gold bullion, working capital, and general corporate purposes.
Clear Street and Needham & Company are the joint book-running managers of the offering.
Public Offering
BioSig Technologies intends to offer shares of common stock through an underwritten public offering.
Use of Proceeds
The net proceeds from the offering will be used to purchase gold bullion, for working capital, and general corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers of the offering.
- The completion of the offering is subject to market conditions with uncertainties regarding its timing, size, or terms.
- Interested parties should thoroughly read the preliminary prospectus supplement and other related documents before investing in the offering.
BioSig Technologies Inc. aims to raise funds through a public offering to support its strategic initiatives. The company's partnership with Clear Street and Needham & Company indicates strong support for the offering.